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Abstract
In order to investigate the current and past activity of phlebo-
virus and ﬂavivirus in Kosovo, a seroprevalence study among
200 blood donors was performed. Positive results were
obtained for the phleboviruses TOSV and SFNV, and for a ﬂavi-
virus of the Japanese Encephalitis group. No positive results for
TBEV were observed.
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The last decades have been characterized by the emergence
in the human population of new infectious agents from ani-
mal reservoirs, but also by the epidemic resurgence of well-
known arboviral diseases, such as dengue, West Nile and
chikungunya fever [1,2].
Other arboviruses, such as the Toscana virus (TOSV) and
the tick-borne encephalitis virus (TBEV), are known to be
endemic in some European countries. TOSV is mainly found
in the Mediterranean basin, whereas TBEV, which is com-
monly found in central Europe, is expanding its activity area
[3,4]. West Nile virus (WNV), ﬁrstly identiﬁed in tropical
Africa, has emerged as a cause of outbreaks and sporadic
cases in several countries of central, eastern and Mediterra-
nean Europe [5,6].
Little is known about the circulation of these viruses in
the southern Balkans, with the exception of Greece and
Albania, where high seroprevalence of TOSV [3] and TBEV
[4], respectively, has been reported. To increase knowledge
about arbovirus circulation in this European sub-region, we
conducted a seroprevalence study of infection with phlebovi-
rus TOSV and ﬂaviviruses TBEV and WNV among blood
donors in Kosovo.
The study population was represented by blood donors
recruited in the Peja Hospital in north-western Kosovo. Of
the samples collected from the 301 candidate blood donors
screened for donation suitability between 1 January and 30
March 2005, 200 were randomly selected for the study.
Informed consent from each participant was obtained. Socio-
demographic information included age, gender, occupation,
education and area of residence (urban or rural). More
detailed information is provided in a previously published
study [7].
IgG against TOSV were investigated using an enzyme-
linked immunosorbent assay (ELISA) method, which has pre-
viously been described [8].
IgG antibodies against TBEV were detected using a
commercially available ELISA system (FSME IgG and IgM
Immunozym; Progen Biotech GMBH, Heidelberg, Germany).
A standard haemagglutination inhibition (HI) test for TBEV
and WNV was also performed [9]. HI tests were carried out
at pH 6.6, both for TBEV and WNV.
Samples with borderline and positive ELISA results for
TOSV were conﬁrmed using a Plaque Reduction Neutraliza-
tion Test (PRNT) for both TOSV and Sandﬂy Naples virus
(SFNV). Samples with high HI titres for TBEV or WNV were
also tested by PRNT [10].
Overall, 200 blood donors were investigated. Of them,
176 (88%) were male and 24 (12%) female. The median age
was 34 years (range, 18–62 years). Most participants (i.e.
142, 71.7%) were resident in rural areas, whereas 56 (28.3%)
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were resident in urban areas (information was missing for
two individuals). With regard to other demographic vari-
ables, 142 (67%) participants were married, and 145 (72.5%)
had more than 8 years of education.
Eleven of 200 individuals had serum samples reactive for
anti-TOSV antibodies using ELISA; PRNT was positive for
three of them, two for SFNV and one for TOSV.
Using an ELISA for TBEV, two individuals were considered
positive and 10 borderline. Using an HI test for TBEV and
WNV, no positive results for TBEV were observed (anti--
TBEV HI titres <1 : 10 or lower than anti-WNV HI titres).
Anti-WNV HI titres <1 : 10 were detected in 31 of 197
tested sera; low titres (i.e. ranging from 1 : 10 to 1 : 40)
were found for 137 study participants, and high titres (i.e.
‡1 : 80) for 29 participants.
Of the 29 sera with an anti-WNV HI titre ‡1 : 80, 24 were
tested by PRNT for WNV and Usutu virus. No positive
results were obtained for Usutu virus, whereas two of the 24
sera showed a very low PRNT titre of 1 : 10 NT50 for WNV.
The results of our study suggest past activity of different
phleboviruses, such as TOSV and SFNV, in Kosovo. TOSV is
known to circulate in central Italy, where it was ﬁrst identi-
ﬁed, but also in the Italian islands of Sicily and Sardinia, and
in countries such as Spain, Portugal and France. The SFNV,
which was ﬁrstly identiﬁed in southern Italy during World
War II, is no longer detectable in Italy but appears to be
endemic in southern Mediterranean countries such as Algeria
[3] and Turkey [11]. Because several of the samples with an
anti-TOSV positive ELISA result investigated in Kosovo were
negative for both TOSV and SFNV when using PRNT, fur-
ther studies are needed in order to investigate other viruses
of the same serological group, and possibly cross-reacting in
the ELISA test, circulating in this area of the Balkans.
Little information on TBEV circulation is available from
Serbia and other neighbouring countries; no cases have been
reported in Bulgaria, whereas a number of cases have been
reported in Albania, where a seroprevalence of 22% has
been documented, and in northern Greece [4]. Recent out-
breaks of WNV causing human encephalitis have occurred in
several European countries [5]. Recently, serological evi-
dence of WNV infection in horses has been reported in
Croatia [12]. In our study, no sample was seropositive for
TBEV. Indeed, the two positive samples in the ELISA test
could not be conﬁrmed by HI or PRNT. Several serum sam-
ples were found reactive against WNV in HI, which, how-
ever, is prone to cross-reactions against other ﬂaviviruses.
For two of these samples a very low PRNT titre of 1 : 10
was determined, which leaves it unclear whether WNV or
another ﬂavivirus of the Japanese Encephalitis group might be
circulating in this area. Before drawing conclusions, some
limits of the study need to be mentioned. Firstly, in seropre-
valence studies, positivity for IgG does not allow us to distin-
guish between current and past virus activity. The second
limitation of the study is the absence of a clear sampling pro-
cedure. Unfortunately, it is not possible to assess to what
extent the results obtained using a convenience sample of
blood donors may be directly generalized to the general
population. Although blood donors represent a selected pop-
ulation group, they are not likely to differ from other individ-
uals living in the same area in terms of exposure to
arthropod bites. However, the ﬁndings of this study should
be interpreted with caution.
In conclusion, our data suggest that phleboviruses TOSV
and SFNV co-circulate in north-eastern Kosovo. No evi-
dence of TBE circulation was found, but other ﬂaviviruses of
the Japanese Encephalitis group, including WNV, might circu-
late in the same area. However, because indirect techniques
were used, ﬁnal conclusions can not be drawn regarding the
current circulation of these viruses, and studies aimed at iso-
lating and identifying these viral agents should follow this
explorative serosurvey.
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Abstract
In Egypt, the disease burden of viral hepatitis is one of the heavi-
est worldwide. We conducted a survey of hepatitis A virus
(HAV) and hepatitis E virus (HEV) in patients and sewage in
Cairo. Our data showed that HAV (genotype IB) was predomi-
nant over HEV (genotype 3) and was circulating in the popula-
tion and the environment.
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Hepatitis A virus (HAV) comprises a single serotype and
seven genotypes. In Africa and the Middle East, the HAV
strains mostly belong to genotypes IA and IB [1–3]. HAV is
primarily transmitted by the faecal–oral route. HAV is one of
the most resistant enteric viruses in the environment [4].
Hepatitis E virus (HEV) is classiﬁed into four genotypes, 1–4,
the distribution of which varies around the world [5]. The
disease burden of HEV is high in developing countries, where
it causes waterborne outbreaks as well as sporadic hepatitis
[5]. Little is known about HEV in the environment. In our
study, we performed a molecular survey of both viruses in
patients suffering from hepatitis and in sewage collected from
two waste water treatment plants (WWTPs) of Greater
Cairo.
Fifty stool samples were collected from patients with hep-
atitis hospitalized at the Embaba Fever Hospital in Cairo dur-
ing July and August 2007. The patients were between
1.5 years and 15 years of age (mean 5.4 years), and pre-
sented hepatitis-related symptoms. The level of bilirubin was
evaluated for each patient. The stool specimens were col-
lected up to the 16th day after the onset, and were screened
for HAV and HEV. The viruses were quantiﬁed with real-
time RT-PCR: the stool specimens were weighed prior to
extraction of the RNA [6].
We collected 76 samples of raw and treated sewage (4 L
of each) from two WWTPs, located at Zenin and El-Berka in
Greater Cairo, between July 2006 and August 2007. The
characteristics of both WWTPs and the sampling procedure
from July 2006 through February 2007 have been docu-
mented [7]. For July and August 2007, the raw and treated
sewage was collected twice during the ﬁrst and last weeks of
the month. Enteroviruses and HAV were concentrated from
2 L of sewage as described previously [8]. The viral particles
were concentrated in 3 mL of 0.15 M Na2HPO4 (pH 7.4).
The remaining 2 L of sewage were decanted prior to
concentration of the HEV particles by adsorption/elution as
described previously [9]. Viral particles were resuspended in
4 mL of McIlvaine buffer (pH 5) [10]. One millilitre was used
for the extraction of the nucleic acids [6].
Three microlitres and 10 lL of RNA were used for the
detection of HAV in the clinical and environmental samples,
respectively, by RT-PCR with primers H1 and H2 [11]. For
the environmental samples, the results were conﬁrmed by
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